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KEY POINTS 
 
 In-vitro evidence has identified that coagulation is activated by increased oxidative stress, 
though the link and underlying mechanism in humans has yet to be established. 
 We conducted the first randomised controlled trial in healthy participants to examine if 
oral antioxidant prophylaxis alters the haemostatic responses to hypoxia and exercise 
given their synergistic capacity to promote free radical formation. 
 Systemic free radical formation was shown to increase during hypoxia and was further 
compounded by exercise; responses that were attenuated by antioxidant prophylaxis. 
 In contrast, antioxidant prophylaxis increased thrombin generation at rest in normoxia, 
and was restored but only in the face of prevailing oxidation. 
 Collectively, these findings suggest that human free radical formation is an adaptive 
phenomenon that serves to maintain vascular haemostasis. 
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Abstract 
 
In-vitro evidence suggests that blood coagulation is activated by increased oxidative stress 
although the link and underlying mechanism in humans has yet to be established. We 
conducted the first randomised controlled trial to examine if oral antioxidant prophylaxis 
alters the haemostatic responses to hypoxia and exercise. Healthy males were randomly 
assigned double-blind to either an antioxidant (n = 20) or placebo group (n = 16). The 
antioxidant group ingested 2 capsules/day that each contained 500 mg of L-ascorbic acid and 
450 international units (IU) of dl-α-tocopherol acetate for eight weeks. The placebo group 
ingested capsules of identical external appearance, taste, and smell (cellulose). Both groups 
were subsequently exposed to acute hypoxia and maximal physical exercise with venous 
blood sampled pre-supplementation (normoxia), post-supplementation at rest (normoxia and 
hypoxia) and following maximal exercise (hypoxia). Systemic free radical formation 
[electron paramagnetic resonance spectroscopic detection of the ascorbate radical (A• −)] 
increased during hypoxia (15,152 ± 1,193 AU vs. 14,076 ± 810 AU at rest, P < 0.05) and was 
further compounded by exercise (16,569 ± 1,616 AU vs. rest, P < 0.05), responses that were 
attenuated by antioxidant prophylaxis. In contrast, antioxidant prophylaxis increased 
thrombin generation as measured by thrombin-antithrombin complex, at rest in normoxia 
(28.7 ± 6.4 ug/mL vs. 4.3 ± 0.2 ug/mL pre-intervention, P < 0.05) and was restored but only 
in the face of prevailing oxidation. Collectively, these findings are the first to suggest that 
human free radical formation likely reflects an adaptive response that serves to maintain 
vascular haemostasis. 
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Introduction 
 
It has been established that physical exercise (Powers & Jackson, 2008) and arterial 
hypoxaemia (Bailey et al., 2001) independently increase the local and systemic formation of 
ubisemiquinone, superoxide ( ) hydroxyl  and nitric oxide free radicals. Human studies  in  
our laboratory have demonstrated that hypoxia promotes free radical-mediated lipid 
peroxidation subsequent to the metal-catalyzed formation of intermediary lipid-derived 
oxygen-centered alkoxyl (LO•) and carbon-centered alkyl (LC•) radicals that is further 
compounded with the superimposition of acute exercise (Bailey et al., 2004; Bailey et al., 
2009b; Bailey et al., 2010; Bailey et al., 2011b; Bailey et al., 2018). Free radical 
accumulation reduces the endogenous levels of antioxidants, (Bakonyi & Radak, 2004) 
favouring free radical formation and oxidative stress that when in excess, can result in 
cellular membrane damage (Lipinski, 2011). 
The nutritional antioxidants, ascorbate and α-tocopherol are thermodynamically well suited to 
serve as effective aqueous/lipid soluble chain-breaking two electron reductants given their 
thermodynamic hierarchy and corresponding low one electron reduction potentials [E΄ of 
282 mV for the ascorbate radical (A•-)/ascorbate monoanion (AH-) couple (Williams & 
Yandell, 1982) and 480 mV for the α-tocopheroxyl radical (TO•)/α-tocopherol couple (Simic, 
1990)] that are comfortably positioned above most oxidizing species. Furthermore, in 
combination, they can work synergistically to prevent lipid peroxidation given the 
thermodynamic capacity of ascorbate to repair (∆E΄≈ +200 mV) TO• (Tappel, 1968; Packer 
et al., 1979; Sharma & Buettner, 1993). In support, oral prophylaxis with ascorbate and α- 
tocopherol has previously been shown by our group to attenuate systemic LO•-LC• formation 
in young participants free of any coagulopathy and improve vascular endothelial function 
subsequent to increased nitric oxide bioavailability (Richardson et al., 2007; Wray et al., 
2009).  While  the  precise  scavenging  mechanisms  remain  a  matter  of  debate, ascorbate- 
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mediated suppression of    and hydrogen peroxide formation has been identified as the     
most thermodynamically cogent candidate though redox-independent mechanisms given that 
ascorbate can alter expression of α-ketoglutarate-dependent dioxygenases, hypoxia-inducible 
factor-α and enzymes involved in histone methylation, also warrant consideration (Cobley et 
al., 2015). 
Inspiratory hypoxia incurred during exposure to terrestrial altitudes ranging from 4,000-6,542 
m that approximates to an equivalent to more severe stimulus incorporated in the present 
study (FIO2 of 12% ≈ 4, 600 m) has been shown to increase thrombin generation (Le Roux et 
al., 1992; Mannucci et al., 2002). In-vitro evidence (Görlach et al., 2000; Görlach, 2004; 
Herkert et al., 2004) suggests that activation of coagulation is triggered by NADPH oxidase- 
mediated  formation within the blood vessel wall  (Görlach et al., 2002). This activates   
tissue factor in-vivo (Herkert & Gorlach, 2002), triggering thrombin generation. It has also 
been shown that hypoxia shifts the endothelial phenotype towards one in which anticoagulant 
properties are diminished and pro-inflammatory features dominate the endovascular milieu 
(Ten & Pinsky, 2002; Foley & Conway, 2016). However, these studies have been confined to 
the in-vitro setting thus to what extent haemostasis is subject to redox-regulation in the in- 
vivo human remains to be established. 
Thus for the first time, we conducted a randomised, double-blind, placebo-controlled 
antioxidant trial in young healthy participants that incorporated acute maximal exercise 
combined with inspiratory hypoxia as established “oxidative stressors”. We hypothesised that 
based on in-vitro findings, hypoxia-induced systemic free-radical formation would be 
associated with activated coagulation and further compounded with the superimposition of 
acute exercise subsequent to more pronounced arterial hypoxaemia. We further hypothesised 
that these responses would be attenuated following antioxidant prophylaxis using a 
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combination of aqueous/lipid soluble chain-breaking antioxidants with an established 
capacity to attenuate systemic free radical-mediated lipid peroxidation. 
Methodology 
Ethical Approval 
The study was approved by the University of South Wales Human Research Ethics 
Committee (UK Ref: LF#27012011). All procedures were carried out in accordance with the 
Declaration of Helsinki of the World Medical Association (Williams, 2008) except for 
registration in a database, and written informed consent was obtained from all participants. 
 
 
Participants 
 
Forty healthy male participants were recruited into the study with a mean ± (SEM) age, 
stature and mass of 25 ± 1 years, 1.81 ± 0.01 m and 84.8 ± 2.1 kg, respectively. Participants 
were native lowlanders, free of any underlying cardiovascular, pulmonary and 
cerebrovascular disease and all were non-smokers. They were asked to refrain from 
consuming any antioxidant supplements or anti-inflammatory medications eight weeks prior 
to experimentation and follow a low nitrate/nitrite diet for 4 days prior to testing. by avoiding 
fruits, salads and cured meats (Wang et al., 1997). They were also asked to refrain from 
caffeine and physical activity for 2 days prior to the study. 
 
 
Design 
 
The study adopted a randomised, double blind, placebo-controlled antioxidant trial and 
consisted of 3 phases incorporating nutritional (antioxidant/placebo) and experimental 
(normoxia/hypoxia/exercise) interventions illustrated in Figure 1 and outlined in detail below: 
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Nutritional Interventions 
 
1. Pre-Supplementation, 2. Supplementation and 3. Post-Supplementation. 
 
During phase 1, participants were tested under resting conditions and randomly assigned to a 
group. During phase 2, they consumed a daily dose of antioxidants or placebo control and in 
phase 3 they were exposed to inspiratory hypoxia and physical exercise. 
 
 
Pre-Supplementation (Phase 1): For baseline pre-supplementation testing, participants 
entered the laboratory at 09:00 following a 12-hour over-night fast and rested in a supine 
position for 30 minutes prior to blood sampling. Intravenous sampling without stasis was 
carried out via venepuncture from a prominent antecubital vein using an 18-Gauge precision 
glide needle (BD Diagnostics, Plymouth UK) into vacutainers (BD Diagnostics, Plymouth 
UK). Following baseline sampling, participants were randomly assigned to either an 
antioxidant or placebo group. 
 
 
Supplementation (Phase 2): The antioxidant group consumed 2 capules/day (during 
breakfast and evening meals) that each contained 500 mg of L-ascorbic acid and 450 
international units (IU) of dl-α-tocopherol acetate (RPL Ltd, Blackpool, UK) for eight weeks. 
The placebo group consumed capsules of identical appearance, taste and smell that each 
contained an equal quantity of plant cellulose extract but of no nutritional value. They 
returned to the laboratory exactly 8 weeks after their initial visit for phase 3 of the 
experiment. 
 
 
Post-supplementation (Phase 3): This phase of the experiment involved baseline, post- 
supplementation testing which served a dual purpose: 1. Ascertaining the effectiveness of 
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phase 2 by checking the blood-borne levels of our target antioxidant vitamins 2: Serving as a 
new baseline before intervention with inspiratory hypoxia and physical exercise. 
 
 
 
Experimental Interventions 
 
Resting measurements in normoxia and hypoxia 
 
During the experimental day, water was available ad libitum and participants were fed a 
protein shake (1.25% cocoa powder, 0.16% chocolate flavouring, 0.1% aspartame and 
98.49% pure whey isolate) made with water (700 mL water: 50g powder) after 3hrs. 
Participants were asked to wake no later than 07:00 on their day of testing and to immediately 
consume their morning dose of supplement or placebo. Upon return to the laboratory at 
09:30, the participants were once again venepunctured, and baseline sampling was carried out 
as in Phase 1. After baseline measurements, they were fitted with a pulse oximeter (Nonin 
Onyx II 9550, Nonin, MN, USA) on their right index finger (Basaranoglu et al., 2015) and 
exposed to normobaric hypoxia ( = 12%) until completion of the experiment. 
Hypoxia was induced using an environmental chamber (Weiss Technik, Ebbw Vale, UK), 
with controlled temperature (21˚C) and relative humidity (50%). The passive exposure period 
lasted 6 hours, during which time participants were asked to remain on a bed in either a 
supine or seated position. At 3 hours of exposure time, participants were given their normal 
dose of either intervention or placebo with water to ensure adequate circulating levels of 
target vitamins. 
 
 
Exercise 
 
Following passive exposure to hypoxia, participants were asked to undertake a standardised 
incremental exercise challenge to volitional exhaustion on an electromagnetically braked 
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cycle ergometer (Lode Corvial, Lode, Groningen, Netherlands) in hypoxia. The test consisted 
of maintaining a cadence of 70 revolutions per minute (RPM) on the ergometer, with power 
output increasing by 35 watts (W) at the end of each minute of exercise. The test was 
complete when the participant fell below 60 RPM for more than 15 seconds or felt they could 
no longer continue. Expired gases were collected via an online metabolic cart (Medical 
Graphics UK, Gloucester UK). 
 
 
Metabolic Measurements 
 
Bloods were centrifuged at 600 g at 4˚C for 10 minutes. Plasma and serum samples were 
decanted into cryogenic vials ((Nalgene® Labware, Thermo Fisher Scientific Inc, Waltham, 
MA, USA) and immediately snap-frozen in liquid nitrogen (N2) and stored at -80°C. Samples 
were left to defrost at 37°C in the dark for 5 min before batch analysis. Unlike a previous 
publication (Fall et al., 2011), we specifically chose not to correct blood-borne analytes for 
plasma volume shifts, notably hypoxia/exercise-induced haemoconcentration, given that 
researchers do not traditionally account for this potential artefact. 
 
 
Chemicals and reagents 
 
These were of the highest available purity from Sigma-Aldrich® (UK). 
 
 
 
Haemostasis 
 
Plasma activated partial thromboplastin time (aPTT), prothrombin time (PT), fibrinogen (FB) 
and D-dimer (DD) were measured using an ACL Futura Plus, automated coagulometer 
(Instrumentation Laboratory, Cheshire UK). Blood was collected at each sampling point into 
sodium citrate Vacutainers (BD Diagnostics, Plymouth UK), spun and separated as described 
in Phase 1 and stored at -80˚C until analysis. aPTT was measured using the HemosIL APTT- 
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SP (liquid) assay, FB and PT were measured using a joint assay HemosIL PT-Fibrinogen HS 
Plus and DD was measured using the HemosIL D-Dimer assay. Thrombin-Antithrombin 
complex (T-AT) was measured using Enzygnost TAT micro (Siemens Medical, Surrey, UK), 
a sandwich enzyme immunoassay for the in-vitro determination of human T-AT. 
Prothrombin Fragment 1&2 (PF1+2) was measured using Enzygnost F1+2 (monoclonal) 
(Siemens Medical, Surrey, UK). F1+2 (monoclonal) is an enzyme immunoassay based on the 
sandwich principle in microtitre format, and based on monoclonal mouse antibodies for the 
in-vitro determination of human PF1+2. The intra and inter-assay CVs were both <5% for all 
measurements. 
 
 
Free radicals 
 
Electron paramagnetic resonance (EPR) spectroscopy was used to directly measure A• − as a 
global biomarker of one electron chemistry in plasma and is compatible with either an 
increased reactivity of systemic free radicals with ascorbate (see later) and/or change in the 
rate of its repair (Bailey et al., 2009a; Bain et al., 2018). Exactly 1 mL of EDTA plasma was 
injected into a high-sensitivity multiple-bore sample cell (AquaX, Bruker Daltonics,  
Billerica, Massachusetts, USA) housed within a TM110 cavity of an EPR spectrometer 
operating at X-band (9.87 GHz). Samples were analysed using a modulation frequency of  
100 kHz, modulation amplitude of 0.65 gauss (G), microwave power of 10 milliwatts (mW), 
receiver gain of 2×105 AU, time constant of 41 ms, magnetic field centre of 3477 G and scan 
width of ± 50 G for 3 incremental scans. After identical baseline correction and filtering, each 
of the spectra were subject to double integration using graphical analysis software (OriginPro 
V.8.5, OriginLab, Massachusetts, USA). The intra and inter-assay CV were both <5%. 
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Antioxidants 
 
Plasma was stabilised and deproteinated using 10% metaphosphoric acid and ascorbic acid 
assayed by fluorimetry based on the condensation of dehydroascorbic acid with 1,2- 
phenylenediamine (Vuilleumier & Keck, 1989). Concentrations of the lipid soluble 
antioxidants (LSA) including α/γ-tocopherol, α/β-carotene, retinol, lycopene, zexanthin, β- 
cryptoxanthin and lutein were determined using an HPLC method (Catignani & Bieri, 1983; 
Thurnham et al., 1988). The intra and inter-assay CV were both <5%. 
 
 
In-vitro study 
 
Concept: In order to disassociate to what extent A• − reflected “authentic” changes in 
systemic free radical formation rather than simply an increase in the circulating concentration 
of substrate (ascorbate) available for oxidation following supplementation, an in-vitro study 
was performed to determine (and retrospectively) correct for the relationship between 
ascorbate and A• −. 
Approach: Varying concentrations of ascorbate (0, 25, 50, 100, 250, 500, 750, 1000 µM) 
were added to phosphate buffer solution (50 mM, pH 7.4) that had been treated with  
chelating resin (Chelex 100) via the batch method and the absence of adventitious catalytic 
metals confirmed as previously outlined (Buettner, 1988). Changes in A• − were recorded as 
outlined above and the corresponding relationship determined between the percent (%) 
increases in ascorbate and A• −. 
 
Statistical analysis 
 
Following confirmation of distribution normality using Shapiro–Wilks tests, data were 
analysed using a two-factor mixed ANOVA incorporating one between (group: antioxidant 
vs. placebo) and one within (condition: rest normoxia vs. rest hypoxia vs. exercise hypoxia) 
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subjects factor. Following a significant main effect and interaction, Bonferroni corrected 
paired samples t-tests were employed to make post hoc comparisons at each level of the 
within-subjects factor. Between-group comparisons were assessed using independent samples 
t-tests. Data are presented as mean ± standard error of mean (SEM) with significance for all 
two-tailed tests set at P < 0.05. 
Results 
Compliance 
Two participants withdrew from the study and 2 reported prior to phase 3 that they had not 
complied with their dosing regimen and were subsequently excluded from the overall 
analysis. Thus, the final data presented are based on a total of 36 participants. The antioxidant 
group (n = 20) were: aged 25 ± 1 years, of stature 179 ± 1 cm, mass 84 ± 3 kg, BMI 26 ± 1 
kg/m2 and the placebo group (n = 16) were: aged 25 ± 1 years, of stature 184 ±2 cm, mass 85 
±3 kg and BMI 25 ± 1 kg/m2 (P > 0.05 for all variables). 
 
 
In-vitro study 
 
The relationship between ascorbate and A• − was found to be logarithmic: 
 
y (% change in A• −) = 138.37 In (x, % change in ascorbate) – 520.79 (r2 = 0.95) 
 
 
Pre-supplementation 
 
Antioxidants: There were no between group differences (P > 0.05) in any of the antioxidants 
(Table 1). 
Free radicals: Figure 2 provides typical examples of observed differences in EPR spectral 
intensities between experimental states with corresponding hydrogen hyperfine coupling 
constants (aH) of ~1.76 G (g = 2.0052). There were no between group differences (P > 0.05) 
in A• − corrected for de-novo oxidation of supplemented ascorbate (Figure 3). 
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Haemostasis: There were differences in prothrombin time (PT) between groups (Figure 4D), 
with the antioxidant group having an elongated PT compared to the placebo group (P < 0.05). 
Other biomarkers of haemostasis showed no differences between groups (P > 0.05, Figure 4, 
A-F). 
 
 
Post-supplementation 
 
Antioxidants: Compared with the placebo, supplementation increased ascorbate (69 vs.104 
ng/mL, P < 0.05). There was no difference in α-tocopherol between groups (38.3 vs.41.2 
mg/mL, P > 0.05) but there was an increase in α-tocopherol pre to post supplementation in 
the antioxidant group (31.38 vs. 41.22 mg/mL, P < 0.05). Retinol increased (P < 0.05) in both 
the antioxidant and placebo groups but there was no difference between groups (1.94 vs. 1.95 
µmol/L, P > 0.05). Supplementation decreased α-carotene in both groups (P < 0.05),  but 
there was no difference between groups (0.04 vs. 0.04 µmol/L P > 0.05). Other antioxidants 
were not affected by 8 weeks of supplementation (Table 1). 
 
 
Free radicals: After correction for the increased circulating bioavailability of the antioxidant 
ascorbate, A• − was shown to decrease in the antioxidant group (9,300 ± 422 vs.14,076 ± 810 
AU, P < 0.05). The decrease in A• − was different compared to pre-supplementation (15,190 ± 
670 AU vs. 9,300 ± 422 AU, P < 0.05) whereas the placebo control group showed no changes 
relative to pre-supplementation (13,586 ± 854 vs.14,076 ± 810 AU, P > 0.05, Figure 3). 
 
 
Haemostasis: After 8 weeks of intervention, plasma thrombin-antithrombin complex (T-AT) 
increased in both groups (P < 0.05,), but more so in the antioxidant group compared with 
placebo (11.8 vs.28.7 µg/mL, P < 0.05 Figure 4, A). Prothrombin fragments 1+2 (PF1+2) 
also increased (P < 0.05) post-intervention (Figure 4, B); the antioxidant group had 
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significantly greater concentrations of PF1+2 post-intervention than the placebo group (126 
vs.198 pmol/L, P < 0.05) and compared to pre-intervention, where the placebo group did not 
change (P > 0.05). PT elongated in both groups post-intervention (P < 0.05) and the 
antioxidant group remained elongated compared to placebo (P < 0.05, Figure 4, D). There 
were no differences in other markers of haemostasis post-intervention. 
Hypoxia 
 
Cardiorespiratory measurements: There were no differences in heart rate or blood oxygen 
saturation between supplementation groups. After 6 hours exposure to hypoxia, resting heart 
rate increased in both the antioxidant and placebo groups [66 ± 2 beats per minute (b/min) vs. 
77 ± 2 b/min, P < 0.05]. After hypoxic exposure, arterial oxyhaemoglobin saturation ( ) 
decreased as expected in both groups (98 ± 1 vs. 82 ± 1 %, P < 0.05). 
Antioxidants: Ascorbate did not increase following exposure to hypoxia vs. normoxia post- 
supplementation in either group. However, the antioxidant group had significantly higher 
levels of ascorbate than the placebo group (114 vs.70 ng/mL, P < 0.05, Table 2). None of the 
LSA were affected by 6 hours of hypoxia and there were no differences either within or 
between groups. 
 
 
Free radicals: A• − was lower in the antioxidant compared with the placebo group (10,583 ± 
443 AU vs.15,152 ± 1,193 AU, P < 0.05). The increase in A• − in the antioxidant group 
compared with normoxia, post-supplementation was not significant (9,300 ± 422 AU 
vs.10,583 ± 443 AU, P > 0.05). Hypoxia increased A• − in the placebo group (14,076 ± 810 
AU vs. 15,152 ± 1,193 AU, P < 0.05, Figure 2). 
 
 
Haemostasis: Plasma T-AT did not change during hypoxia in the placebo or antioxidant 
group. However, the difference between the groups following 8 weeks of intervention was 
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eliminated (Figure 4, A). The Plasma levels of PF1+2 did not alter after exposure to hypoxia, 
but as with T-AT, the difference between groups following intervention was returned to zero, 
following exposure to hypoxia (Figure 3, B). Plasma aPTT was not altered by hypoxia in 
either group (Figure 4, C), PT did not alter through any time point, but as with T-AT and 
PF1+2, post-intervention differences in PT were again eliminated by hypoxia. Plasma 
fibrinogen concentrations were unchanged by hypoxia (Figure 4, E) and there were no 
differences between the intervention groups. D-dimer, the biomarker of blood fibrinolysis 
also remained unaltered by this stimulus and between groups (Figure 4, F). 
 
 
Exercise 
 
Cardiorespiratory measurements: Immediately following exercise, remained lower 
compared to normoxia (98 ± 1 % vs. 86 ± 6%, P < 0.05). Exercise increased heart rate vs. 
normoxia and vs. resting hypoxia (66 ± 2 b/min vs. 77 ± 2 b/min vs. 115 ± 3 b/min, P < 0.05). 
 
 
Antioxidants: As with hypoxia, there were no changes in antioxidants following maximal 
exercise. Ascorbate remained unchanged compared to normoxia, post-supplementation and in 
resting exposure to hypoxia, but remained elevated (P < 0.05) compared to placebo (Table 2). 
 
 
Free radicals: Normalised A•− remained lower in the antioxidant compared to the placebo 
group (10,984 ± 529 AU vs.16,569 ± 1,618 AU, P< 0.05, Figure 3). In the antioxidant group, 
normalised A•− increased vs. normoxia, post-supplementation (10,984 ± 529 AU vs. 9,300 ± 
529 AU, P < 0.05) and placebo group experienced a similar increase (16,569 ± 1,616 AU 
vs.15,993 ± 1,193 AU, P < 0.05). 
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Haemostasis: Exercise increased T-AT in the placebo group (P < 0.05), but not in the 
antioxidant group (Figure 4, A). While PF1+2 did not change following exercise (Figure 4, 
B) aPTT shortened in both groups (P < 0.05, Figure 4, C). PT, fibrinogen and D-dimer were 
unaltered by exercise (Figure 4, D-F). 
 
 
Discussion 
 
The present study has revealed two primary findings. First, and as anticipated, hypoxia and to 
a greater extent, exercise were shown to promote systemic free radical formation, responses 
that were attenuated by antioxidant prophylaxis. In contrast, and indeed contrary to our 
original hypothesis, antioxidant prophylaxis increased thrombin generation at rest in 
normoxia, and was restored but only in the face of prevailing oxidation. Collectively, these 
findings are the first to suggest that human free radical formation likely represents an 
adaptive phenomenon that serves to maintain vascular haemostasis. 
 
 
Supplementation 
 
The combined increases in the systemic concentration of ascorbate and α-tocopherol confirms 
that our participants adhered to the supplementation regimen. This was associated with a 
corresponding reduction in A•− (corrected for de-novo oxidation of supplemented ascorbate) 
highlighting a genuine reduction in systemic free radical formation. Following 
supplementation, the increase in both PF1+2 and T-AT implies increased thrombin 
generation (Chandler and Velan, 2003) and antithrombin activity (Mannucci, 1994). These 
data suggest that increased thrombin generation was accompanied by a concomitant increase 
in the enzyme-inhibitor complex. These data also indicate that global coagulation cascade 
times and fibrinolysis, as measured by D-dimer, remained unaltered. Collectively, these 
findings challenge the prior research of Wang et al., (2009) who found that pre-treatment 
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with chain breaking antioxidant vitamins suppressed thrombin generation albeit within a 
thrombophilic setting. 
 
 
 
Hypoxia 
 
The concentration of ascorbate in human plasma is orders of magnitude greater than any 
number of free radicals that exhibit E΄ > 282 mV (i.e. comparatively more oxidised in terms 
of thermodynamic hierarchy or “pecking order”) associated with the A• −/AH- couple 
(Buettner, 1993). Thus, when these species are generated within the systemic circulation, they 
have the thermodynamic potential to react endogenously with this terminal small-molecule 
antioxidant to form the distinctive A• − doublet [(R• + AH-  A• − + R-H] that is readily 
observable using EPR spectroscopy (Buettner, 1993). Thus, the elevation in A• − combined 
with an inverse relationship with SaO2 provides direct evidence that hypoxaemia increased 
systemic free radical formation consistent with our previous findings (Bailey et al., 2009). 
Hypoxia was also associated with normalisation of the supplementation-mediated increase in 
thrombin generation, disagreeing with the current literature. For example, chronic obstructive 
pulmonary disease (COPD) (Donaldson et al., 2010) and obstructive sleep apnoea (Yaggi et 
al., 2005) predispose patients to stroke and it is currently thought that this is attributable to 
systemic oxidation (Donaldson et al., 2010). Notwithstanding other, potentially confounding 
co-morbidities, the increased risk of atherothrombotic events associated with arterial 
hypoxaemia may thus be linked to free radical-mediated activation of coagulation. 
Previous data from our laboratory also suggest that hypoxia alone and in combination with 
acute exercise, known to compound systemic oxidative stress, activate coagulation by 
shortening activated partial thromboplastin time (Fall et al., 2011). However, the present data 
fail to support this. The reduction in PF1+2 and T-AT suggests that in contrast to what we 
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originally anticipated, free radical formation during hypoxia normalised the previously 
thrombophilic profiles of the antioxidant group yet failed to affect the placebo group. 
Therefore, the data suggest that free radical formation decreases (and not increases, as we 
anticipated) thrombin generation, contrary to the limited findings reported in-vitro. 
Previously, authors have suggested that the hypoxia-induced increase in thrombin generation 
was associated with oxidised low density lipoprotein (LDL-OX)-mediated increased 
assembly of the prothrombinase complex (Rota et al., 1997) and oxidative stress increased  
the bioactivity of factor VIII by an as of yet, unknown mechanism (Koprivica et al., 2011). 
The existing literature regarding the thrombogenicity of hypoxia remains conflicting and our 
findings collectively support those that state that hypoxia alone fails to alter blood 
coagulation (Andrew et al., 1987; Crosby et al., 2003; Hodkinson et al., 2003; Fall et al., 
2011; Fall et al., 2015). 
 
 
Exercise 
 
We have consistently shown that exercise in hypoxia increases A• −, LO• and LC• (Davison et 
al., 2006; Bailey et al., 2011a; Woodside et al., 2014; Bailey et al., 2018). In the present 
study, T-AT increased following exercise in hypoxia in the placebo group but remained 
unchanged in the antioxidant group. The activation of antithrombin and subsequent 
generation of T-AT can be interpreted as a consequence of thrombin generation (Burns et al., 
2003). Collectively, we interpret these findings to reflect exercise-induced activation of 
coagulation in the placebo group only, and that antioxidant prophylaxis negated this. PF1+2 
remained unchanged following the exercise challenge and therefore these data suggest that 
the activity of factor X (the principal agent in the conversion of prothrombin to thrombin) 
was likely unaffected by exercise. This leads to the conclusion that T-AT is elevated because 
of an increase in the activity of antithrombin (Chandler & Velan, 2003) per se and not as a 
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consequence of increased thrombin generation. To the authors’ knowledge, this is a novel 
finding and could possibly explain previous studies that have shown attenuation of 
coagulation during hypoxic exercise (DeLoughery et al., 2004). The half-life of PF1+2 is ≈ 
90 min (Mannucci, 1994) and thus it would be interesting to extend the time-course in 
follow-up studies or incorporate an alternative biomarker such as fibrinopeptide A given its 
comparatively shorter half-life (≈5 mins) (Mannucci, 1994). 
Activated partial thromboplastin time was shortened post-exercise in both groups, reflecting 
increased activity of the contact factor pathway of coagulation consistent with our previous 
research (Fall et al., 2011) and PT remained unchanged which suggests the tissue factor 
pathway was unaltered. This finding corresponds with research suggesting that exercise 
promotes expression of vWF (Stakiw et al., 2008), leading to an increase in the vWF-FVIII 
complex, increasing the activity of the intrinsic coagulation pathway. Furthermore, activation 
of the coagulation cascade coincided with the increase in A• −. Recent research in animal 
models also shows that NADPH oxidases generate promoting platelet activation 
(Delaney et al., 2016). 
 
It is also known that oxidised lipoproteins support the assembly of the Va/Xa 
(prothrombinase) complex (Rota et al., 1998) and as such increase thrombin generation as 
indeed our findings corroborate. Furthermore, studies in patients with antiphospholipid 
syndrome, which promotes a hypercoagulable state have demonstrated that coagulation is 
activated by oxidative stress via over-expression of monocyte tissue factor (Ferro et al., 
2003). Without the analysis of PF1+2 and T-AT, these data would suggest increased 
coagulation activation and support the hypoxic findings of Wang and colleagues (2009). 
Interestingly, the conversion of prothrombin to thrombin is controlled by both pathways and 
suggests that despite the shortening of aPTT, that there is an inhibitory mechanism that free 
radicals exert over coagulation and this lies in the activation of antithrombin per se. 
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In contrast, fibrinolysis as measured by D-dimer, remained unaltered throughout the course of 
the study. This is of interest because acute exercise and exercise training has been shown to 
increase fibrinolysis in healthy men and in patients with vascular disease (Womack et al., 
2003; Killewich et al., 2004). The present data suggest that hypoxia suppresses this, but 
interestingly Womack and colleagues (2003) argue that the fibrinolytic response to exercise is 
governed by a participant’s baseline “fibrinolytic potential”, i.e. the ability to increase 
fibrinolysis in response to a pro-coagulant stimulus. It is possible that hypoxia is suppressing 
the fibrinolytic potential of our participants (Mannucci et al., 2002) and that this phenomenon 
is equally subject to redox regulation in-vivo , most likely via a free radical mediated increase 
in PAI-1 (the principle inhibitor of fibrinolysis) expression. 
 
 
Conclusions 
 
The combined application of state-of-the art analytical techniques with an experimental 
model of hypoxia and exercise known to increase free radical formation, has identified that 
antioxidant prophylaxis increased resting thrombin generation in normoxia and this was 
restored only in the face of prevailing oxidation. These findings are the first to suggest that 
human free radical formation likely represents an adaptive phenomenon that serves to 
maintain vascular haemostasis, reflecting the hormetic-haemostatic benefits of oxidative 
stress as we have recently postulated (Bain et al., 2018). Since arterial hypoxaemia in human 
circulatory disease is associated with oxidative stress and thrombophilia, further research is 
required to differentiate physiologically adaptive from pathologically maladaptive oxidation. 
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Legends 
 
Figure 1: Experimental schema of the randomised double-blind placebo-controlled 
antioxidant study 
 Blood sampling; FIO2, fraction of inspired oxygen 
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Figure 2: Typical electron paramagnetic resonance (EPR) spectra of the ascorbate free 
radical. 
EPR spectra are from the venous circulation of a single participant from the placebo group in 
normoxia pre/post (placebo) supplementation, following 6 hours passive exposure to hypoxia 
(12% O2) and maximal exercise in hypoxia. All spectra were filtered and scaled identically in 
arbitrary units (AU). A•- appears as a (filtered) doublet with a hydrogen hyperfine coupling 
constant (a β) of ~1.76 Gauss (see insert of A for simulated spectrum). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effects of supplementation, inspiratory hypoxia and exercise on systemic free 
radical formation. 
Values are corrected for de-novo oxidation of supplemented ascorbate in-vitro (see Methods). 
Values are mean ± SEM error bars. †different vs. placebo group (P < 0.05), * different within 
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group vs. pre-supplementation normoxia (P < 0.05) and **different within group vs. post- 
supplementation normoxia (P< 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Effects of supplementation, inspiratory hypoxia and exercise on coagulation 
and fibrinolysis. 
Values are mean ± SEM. T-AT, thrombin-antithrombin complex; PF, prothrombin fragment; 
aPTT, activated partial thromboplastin time; PT, prothrombin time. *different within groups 
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vs. pre-supplementation normoxia (P < 0.05), **different within groups vs. post 
supplementation hypoxia (P < 0.05); †different between groups (P < 0.05). 
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Table 1. Effects of supplementation on antioxidants 
Group Placebo group (n = 16) Antioxidant group (n = 20) 
Ascorbate 
(ng/mL) 
74.5 ± 
4.0 
68.8 ± 4.1 -5.7 70.0 ± 4.1 
104.2 ± 
11.7*† 
34.2 
Wray DW, Uberoi A, Lawrenson L, Bailey DM & Richardson RS. (2009). Oral antioxidants 
and cardiovascular health in the exercise-trained and untrained elderly: a radically 
different outcome. Clinical Science 116, 433-441. 
 
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM & Mohsenin V. (2005). 
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. New England Journal 
of Medicine 353, 2034-2041. 
 
 
 
 
 
 
 
 
 
 
 
 
Inspirate  Normoxia   Normoxia  
Phase Pre Post Δ Pre Post Δ 
 
 
 
 
α-tocopherol 
(mg/mL) 
33.3 ± 
2.2 
38.3 ± 3.1 5.0 31.4 ± 2.8 
41.2 ±
 
3.5* 
 
9.8 
 
γ-tocopherol 
(mg/mL) 
 
3.4 ± 0.3 1.9 ± 0.5* 1.6 3.3 ± 0.4 1.6 ± 0.2 -1.7 
 
Retinol (µmol/L) 
1.11 ±
 
0.36 
 
Lutein (µmol/L) 
0.10 ± 
0.02 
1.94 ± 
0.92* 
0.14 ± 
0.02 
0.83 
1.18 ± 
0.10 
 
0.04 
0.13 ± 
0.02 
1.95 ± 
0.17* 
0.15 ± 
0.02 
 
0.77 
 
 
0.02 
 
Zeaxanthin 
(µmol/L) 
0.05 ± 
0.01 
0.05 ± 
0.005 
0.00 
0.04 ± 
0.005 
0.04 ± 
0.004 
 
0.00 
 
β-cryptoxanthin 0.09 ± 0.08 ± -0.01 0.09 ± 0.07 ± -0.02 
This article is protected by copyright. All rights reserved.  
Group Placebo group (n = 16) Antioxidant group (n = 20) 
Ascorbate 
(ng/mL) 
68.8 ± 4.1 70.1 ± 4.9 71.9 ± 5.1 
104.2 ± 
11.7 
113.8 ± 
7.4 
111.0 ± 
8.5† 
(µmol/L) 0.01 0.01 0.05 0.03 
 
α-carotene 
(µmol/L) 
β-carotene 
(µmol/L) 
Lycopene 
(µmol/L) 
 
0.39 ± 
0.06 
0.80 ± 
0.19 
3.82 ± 
0.23 
 
0.04 ± 
0.08* 
0.14 ± 
0.03* 
0.12 ± 
0.01* 
0.35 
0.38 ± 
0.08 
 
0.66 
0.73 ± 
0.16 
 
3.70 
3.38 ± 
0.47 
 
0.04 ± 
0.01* 
0.12 ± 
0.02* 
0.13 ± 
0.02* 
 
-0.34 
 
 
-0.61 
 
 
-3.25 
 
 
Values are means ± SEM. *different to pre-supplementation for given group (P < 0.05); † 
different to placebo for given phase of supplementation (P < 0.05). 
 
 
 
 
 
Table 2. Effects of hypoxia and exercise on antioxidants following supplementation 
 
 
 
Inspirate Normoxia Hypoxia Hypoxia Normoxia Hypoxia Hypoxia 
State Rest Rest Exercise Rest Rest Exercise 
 
 
 
 
α-tocopherol 
(mg/mL) 
 
38.3 ± 3.1 39.0 ± 3.2 42.8 ± 3.8 41.2 ± 3.5 44.4 ± 4.4 46.0 ± 3.3 
 
γ-tocopherol 
(mg/mL) 
1.90 ± 0.52 
2.05 ±
 
0.45 
1.57 ± 
0.28 
1.58 ± 0.20 2.89 ± 1.0 
3.05 ±
 
0.50 
 
Retinol 
(µmol/L) 
Lutein 
1.94 ± 0.10 
1.69 ±
 
0.12 
 
0.14 ± 0.02 
0.13 ±
 
2.16 ± 
0.08 
0.15 ± 
1.95 ± 0.17 
1.87 ±
 
0.12 
 
0.15 ± 0.02 
0.14 ±
 
2.09 ± 
0.27 
0.15 ± 
 
 
 
 
 
β- 
cryptoxanthin 
0.08 ± 0.01 
0.07 ±
 
0.01 
0.09 ± 
0.12 
0.07 ± 0.03 
0.06 ±
 
0.05 
0.07 ± 
0.04 
(µmol/L)  0.02 0.02  0.01 0.02 
Zeaxanthin 0.05 ± 0.05 ± 0.05± 0.04 ± 0.04 ± 0.05 ± 
(µmol/L) 0.005 0.005 0.005 0.004 0.003 0.005 
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(µmol/L) 
 
α-carotene 
(µmol/L) 
 
0.04 ± 0.08 
0.04 ±
 
0.07 
 
 
0.05 ± 
0.07 
 
 
0.04 ± 
0.007 
 
 
0.03 ± 
0.05 
 
 
0.03 ± 
0.003 
 
β-carotene 
(µmol/L) 
Lycopene 
(µmol/L) 
0.13 ± 0.03 
0.12 ±
 
0.02 
 
0.12 ± 0.01 
0.11 ±
 
0.01 
0.15 ± 
0.03 
0.15 ± 
0.02 
0.12 ± 0.02 
0.09 ±
 
0.02 
 
0.13 ± 0.02 
0.11 ±
 
0.02 
0.07 ± 
0.01 
0.11 ± 
0.02 
 
 
 
 
Values are means ± SEM. †different to placebo group for given inspirate and state (P < 0.05). 
